Dj Broadcom Stock, With Google's Gemini Premium, Holds Near Highs Ahead Of Q4 Results - Ibd

Reuters

Risk Warnings and Disclaimers

You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.

Add to Favorites

Dj Ibd: Broadcom Stock, With Google's Gemini Premium, Holds Near Highs Ahead Of Q4 Results

Reuters

Risk Warnings and Disclaimers

Add to Favorites

Micron, Salesforce among market cap stock movers on Friday

Investing.com

Friday’s market has seen swings in various stocks based on news and other factors. Today, stocks like Salesforce (CRM) and Rubrik (RBRK) are rallying, while stocks like WR Berkley (WRB) and DocuSign (DOCU) are falling. Below are highlights of some of the biggest stock movers, from mega-caps to small caps.

Mega-Cap Movers ($200 billion USD or higher)

Salesforce (CRM) +4.31%
Micron Technology (MU) +3.24%
Advanced Micro Devices ( +2.39%
Avago Technologies (AVGO) +1.96%

Large-Cap Stock Movers ($10-$200 billion USD)

Rubrik (RBRK) +26.65%
Samsara (IOT); Samsara beats Q3 expectations with 29% revenue growth, shares slip +15.08%
Ulta Salon Cosmetics & Fragrance (ULTA) +13.56%
Albemarle (ALB); Albemarle stock rating upgraded by UBS on lithium market deficit forecast +7.51%
Cooper Companies Inc (COO); CooperCompanies names Colleen Jay as new board chair effective January +8.17%
Lattice Semiconductor (LSCC); Lattice Semiconductor announces $250 million share repurchase program +5.57%
Social Capital Hedosophia V (SOFI); SoFi prices $1.5 billion public offering of common stock -5.71%
AltC Acquisition (OKLO); Needham initiates Oklo stock with Buy rating, $135 price target -5.65%
DocuSign Inc (DOCU) -6.16%
WR Berkley Corp (WRB); Mitsui Sumitomo acquires 12.5% stake in W. R. Berkley -7.46%

Mid-Cap Stock Movers ($2-$10 billion USD)

Praxis Precision Medicines Inc (PRAX); Praxis Precision Medicines advances toward NDA submission for tremor drug +43.41%
Victoria’s Secret Co (VSCO) +17.69%
Vera Therapeutics (VERA) +5.06%
Parsons Corp (PSN); Parsons stock downgraded by Raymond James after losing FAA contract -22.28%
Argan (AGX); Argan shares plunge over 10% on top-line miss in Q3 -13.77%
SentinelOne (S); SentinelOne shares slide 6% on weak Q4 revenue guidance -10.11%
Adaptive Biotechnologies Corp (ADPT) -9.82%
CleanSpark (CLSK) -4.76%
Cinemark Hldg (CNK) -4.74%

Small-Cap Stock Movers ($300 million - $2 billion USD)

Ambitions Enterprise Management Co (AHMA) -32.65%
Domo Inc (DOMO); Domo shares tumble 17% as Q3 results fail to impress -19.27%
Immatics NV (IMTX) -15.46%
Compass Diversified Holdings (CODI) -12.26%
Alumis (ALMS) +20.84%
Smith & Wesson (SWBI) +17.06%
New Fortress Energy LLC (NFE); New Fortress Energy secures 7-year gas supply deal for Puerto Rico +16.79%
Dingdong ADR (DDL) +10.26%
Pepco Holdings Inc-Exch (POM) +10.65%
Borr Drilling Ltd (BORR) +9.04%

For real-time, market-moving news, join Investing Pro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Risk Warnings and Disclaimers

Add to Favorites

Transforming Healthcare Data With Oracle Health Data Intelligence

Acceswire

Oracle

+0.51%

A unified approach to turning information into insights

CHICAGO, IL / ACCESS Newswire / December 5, 2025 / Authored by Baker Tilly's Meghan Loomis and Ed Ricks

Healthcare organizations are under increasing pressure to improve outcomes, manage rising costs and operate more efficiently, all while navigating data that lives in fragmented clinical, financial and operational systems. Oracle Health Data Intelligence brings these pieces together, creating a connected, cloud-based foundation that helps organizations understand performance and make more informed decisions.

What is Oracle Health Data Intelligence?

OHDI is an electronic health record (EHR) agnostic, modular platform built on Oracle Cloud Infrastructure. It centralizes data from across the healthcare ecosystem and applies analytics, automation and artificial intelligence (AI) to help teams use information more strategically. At its core, the platform supports cleaner, more complete data; visibility into performance trends; and decision-making tools that guide quality care and operational improvement.

Oracles Health Data Intelligence integrates data from EHRs, claims, care management platforms, social determinants of health and operational systems to create one standardized, longitudinal view of relevant data. With a comprehensive record of patient and population activity, healthcare organizations can see the full patient journey and track performance without navigating disconnected systems. Its scalable, interoperable design allows clients to integrate data at their own pace while reducing silos and strengthening the foundation for advanced analytics.

Turning data into insights

Once data is unified, Oracle Health Data Intelligence provides tools that help leaders interpret what it means and act on it. Together, these capabilities help healthcare organizations turn raw data into actionable insights that strengthen both patient outcomes and operational performance.

Analytics dashboards: Visualizing trends in quality, utilization and cost. Teams can identify care gaps, monitor performance metrics over time and prioritize initiatives based on real data.
Predictive models: Identifying high risk patients and supporting earlier interventions. By flagging high-risk individuals, care teams can tailor outreach with the aim of reducing avoidable complications or hospitalizations.
Population health and cohort management tools: Segmenting patient populations based on risk, conditions or social factors to target interventions and allocate resources.
Performance insights: Supporting value-based programs, regulatory reporting and financial planning. Leaders can monitor trends across departments, anticipate needs and connect clinical performance with cost and operational efficiency.
AI-enabled features: Summarizing patient histories, supporting care management decisions and reducing administrative burden for clinicians.

Oracle's growing role in healthcare

Oracle Health Data Intelligence reflects Oracle's broader effort to build a more connected, intelligent healthcare environment. Through advancements in cloud technology, interoperability and AI, Oracle is working to simplify how data flows across systems and how teams use that information to guide care. Recent enhancements such as expanded analytics libraries and AI-enabled summarization tools highlight Oracle's push toward predictive insights and more coordinated, proactive care.

Looking ahead: A more connected, insight driven future

Healthcare is evolving, and organizations must move beyond data to actionable insights that support better outcomes, operational efficiency and patient experiences. Oracle Health Data Intelligence provides a scalable foundation for connecting clinical, operational and financial information, helping teams make informed decisions in real time.

By unifying data, surfacing key trends and enabling predictive insights, the platform supports both immediate priorities and long-term transformation. For healthcare leaders focused on improving analytics maturity, strengthening care coordination and elevating performance, Oracle Health Data Intelligence offers a practical path forward.

Technology is always changing, however, your mission to create excellent patient experiences while maintaining broader operational outcomes is not. Let Baker Tilly's Oracle Cloud and healthcare experience help you modernize your systems to deliver better patient experiences while keeping up with your broader operational outcomes.

Interested in learning more? Connect with a Baker Tilly specialist.

View additional multimedia and more ESG storytelling from Baker Tilly on 3blmedia.com.

Contact Info:

Spokesperson: Baker Tilly

Website: https://www.3blmedia.com/profiles/baker-tilly

Email: info@3blmedia.com

SOURCE: Baker Tilly

View the original press release on ACCESS Newswire

Risk Warnings and Disclaimers

Add to Favorites

Buy shares of this AI winner into earnings next week: Mizuho

Investing.com

Ategrity Specialty Insurance

-2.60%

Advanced Micro Devices

+1.25%

Investing.com -- In a note to clients on Friday, Mizuho named the stock that it is buyers of heading into earnings next week, with analyst Vijay Rakesh telling clients he is bullish on the name as AI demand accelerates into 2026.

Mizuho reiterated its Outperform rating and $435 price target on Broadcom, arguing that it is positioned for “further 2026 AI compute offload upside into earnings.”

Get premium news and insight, AI stock picks, and deep research tools by upgrading to InvestingPro - get 55% off today

Mizuho said Broadcom’s AI opportunity is expanding meaningfully as Google’s Gemini 3 ramps and TPU adoption spreads across major frontier-model developers, including Meta, Apple and Anthropic.

The firm wrote that an “expanding TPU reach… position[s] key manufacturing partner AVGO to see upside into 2026E,” noting that Broadcom’s TPUv7p and TPUv8p chips carry estimated average selling prices of ~$10,000 and ~$15,000.

If Google gains traction, the revenue implications could be substantial, Mizuho added.

The firm also highlighted a new set of networking catalysts. It said Broadcom remains “a networking beneficiary with TPU Scale-Up and ESUN with META into 2026,” pointing to Ethernet-led architectures that could grow to roughly 25% of networking revenue next year.

Broadcom’s next-generation Tomahawk 6-Davisson switch, which offers “>70% lower power needs,” and the new Thor Ultra 800G NIC were also cited as competitive strengths.

Mizuho sees multiple ASIC ramps between 2026 and 2028 and stated that the company’s AI revenue estimates for fiscal years 2027 and 2028 are above the Street.

For fiscal 2026, the firm expects $86.9 billion in revenue and $9.34 in EPS, with AI revenue of $41.1 billion, again above consensus.

With revenue growth expected to exceed 30% next year and accelerate further in 2027, Mizuho believes Broadcom offers a rare combination of scale, visibility and upside, concluding: “We are buyers on AVGO heading into earnings next week.”

Risk Warnings and Disclaimers

Add to Favorites